Clinical Trial Update: BTT1023 in Psoriasis [Phase 1]

View source ↗

Summary

Biotie Therapies completed a Phase 1 study of BTT1023 in plaque psoriasis.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Plaque Psoriasis

Drugs mentioned

• BTT1023

Snippet

Sponsor: Biotie Therapies Corp. | Conditions: Plaque Psoriasis | Phase 1 | Status: COMPLETED